Long-term remission of recalcitrant tumour-stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin.
Advanced stage mycosis fungoides (MF) generally has a poor prognosis, and currently there is no standard treatment available. Here we report the case of a young woman with recalcitrant tumour-stage MF (T3, stage IIb) whose disease was unresponsive to several therapeutic modalities, but who has showed sustained clinical response to pegylated liposomal doxorubucin. No severe infectious complications have been observed. The use of this drug in tumour-stage MF should be investigated further.
Tsatalas
C
C
Department of Haematology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. ktsatala@med.duth.gr
Martinis
G
G
Margaritis
D
D
Spanoudakis
E
E
Kotsianidis
I
I
Karpouzis
A
A
Bourikas
G
G
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008081:Liposomes; D009182:Mycosis Fungoides / Q000188:drug therapy*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008081:Liposomes; D004317:Doxorubicin